Cellectis S.A.

Historical 13F Holders

Symbol
CLLS
CUSIP
15117K103
All holders as of
Q2 2026
Type
Equity
Class
SPON ADS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 15117K103 since 12/18/2024, largest first.

Filer % of Class Filed
AstraZeneca PLC 13D/A
44.0% 1/24/2025
Event 1/23/2025
Bpifrance Participations SA 13D/A
11.1% 12/12/2025
Event 12/3/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Long Focus Capital Management, LLC 13G/A
4.6% 2/11/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 1 35.0 k $52.9 k
2026 Q2 27 9.48 M $28.4 M
2026 Q1 32 10.2 M $32.5 M
2025 Q4 34 10.5 M $51.1 M
2025 Q3 31 8.32 M $23.7 M
2025 Q2 25 11.8 M $17.9 M
2025 Q1 28 13.6 M $16.9 M
2024 Q4 32 12.8 M $23.0 M
2024 Q3 31 9.77 M $20.9 M
2024 Q2 33 9.86 M $18.4 M
2024 Q1 36 10.0 M $26.6 M
2023 Q4 42 9.89 M $30.5 M
2023 Q3 35 11.5 M $18.1 M
2023 Q2 40 14.0 M $27.6 M
2023 Q1 35 15.2 M $29.3 M
2022 Q4 43 8.73 M $18.3 M
2022 Q3 52 10.3 M $23.6 M
2022 Q2 47 10.8 M $30.7 M
2022 Q1 57 12.4 M $56.4 M
2021 Q4 66 15.2 M $127 M
2021 Q3 75 15.4 M $194 M
2021 Q2 84 16.3 M $253 M
2021 Q1 87 15.3 M $310 M
2020 Q4 99 16.4 M $464 M
2020 Q3 77 14.3 M $264 M
2020 Q2 82 13.9 M $247 M
2020 Q1 72 15.7 M $145 M
2019 Q4 64 13.2 M $227 M
2019 Q3 65 13.1 M $137 M
2019 Q2 82 13.9 M $217 M
2019 Q1 66 12.7 M $234 M
2018 Q4 68 11.5 M $191 M
2018 Q3 86 11.5 M $326 M
2018 Q2 92 11.3 M $319 M
2018 Q1 74 7.07 M $223 M
2017 Q4 63 7.31 M $213 M
2017 Q3 49 5.87 M $167 M
2017 Q2 46 5.26 M $136 M
2017 Q1 45 5.74 M $138 M
2016 Q4 43 5.80 M $98.2 M
2016 Q3 40 6.64 M $160 M
2016 Q2 39 6.96 M $185 M
2016 Q1 44 6.47 M $178 M
2015 Q4 48 7.05 M $219 M
2015 Q3 44 7.10 M $187 M
2015 Q2 40 6.60 M $238 M
2015 Q1 44 6.12 M $212 M